Description
Ranbaxy Laboratories Limited (BSE: 500359) is an Indian multinational pharmaceutical company that was incorporated in India in 1961. The company went public in 1973 and Japanese pharmaceutical company Daiichi Sankyo acquired a controlling share in 2008
Ranbaxy’s
REVITAL
Revital is a brand of health supplement.
Provides unique combination of vitamin, minerals and Chinese herbal drug ginseng. India’s largest selling daily health supplement. Flagship brand of Ranbaxy global consumer health. Introduced as prescription drug in the year 1993. Switched over as OTC drug in 2003 Recognized among top five selling OTC products in India.
Ranbaxy Labs. Ltd.
Established in 1961 ; India’s largest pharmaceutical company. Ninth largest generic company of the world; sales in 125 countries. 9th most trusted brand of the world. Share of 4.8 % in Indian pharmaceutical market. Total revenue of 85507 millions in 2009-10 , 70% of which were generated from exports.
Partnership with Japan’s Daiichi Sankyo in 2008.
Ranbaxy Global Consumer Healthcare in 2002.
Revenue of $ 54 mn with annual growth of 23 % in 2010.
Product
? Revital
? Revital Women
Price
Blister pack of 10 capsules 75 Rs.
Plastic pack of 30 capsules 180 Rs.
Place
1000 distributors in 865 cities. Sold from chemists, general stores and super markets.
11%
Sales Outlets
Chemists General stores Super markets
20%
69%
Segmentation
Men in the age group above 30. All population over the age group of 16
Targeting
Sports persons, professionals and recovering patients.
Men women and diabetes patients.
Positioning
Health supplement for highly active men recovering men. Daily health supplement for everyone above the age of 16
“Jiyo jee bhar ke”
Sales
Largest selling product of Ranbaxy. FY 2010 total revenue of Rs.132 crore. Among top five OTC brands Market Share
Revital
4%
Supractive
9%
Others
87%
Product Life Cycle
180 160 140 120 100 80 60 40
20 0
yr yr yr yr yr yr yr yr yr yr yr 1993 1995 1997 1999 2001 2003 2005 2007 2009 2011 2013
• Low cost of production • Wide distribution channel • Large pool of installed capacities
• Dependence on raw material • Low R & D
S O
• Far saturation point • Health awareness
W
T
• Increasing sales cost • Imitation
References
? en.wikipedia.org/wiki/Revital ? www.myrevital.com/faq.html ? www.ranbaxy.com/investorinformation/annual_pr2010.aspx
? www.ranbaxy.com/investorinformation/finance_archive.aspx
? www.expresspharmaonline.com/.../management02.shtml ? www.slideshare.net/imc-campaign-for-revital-ranbaxy-5914513 - United States
Thank You
doc_614677791.pptx
Ranbaxy Laboratories Limited (BSE: 500359) is an Indian multinational pharmaceutical company that was incorporated in India in 1961. The company went public in 1973 and Japanese pharmaceutical company Daiichi Sankyo acquired a controlling share in 2008
Ranbaxy’s
REVITAL
Revital is a brand of health supplement.
Provides unique combination of vitamin, minerals and Chinese herbal drug ginseng. India’s largest selling daily health supplement. Flagship brand of Ranbaxy global consumer health. Introduced as prescription drug in the year 1993. Switched over as OTC drug in 2003 Recognized among top five selling OTC products in India.
Ranbaxy Labs. Ltd.
Established in 1961 ; India’s largest pharmaceutical company. Ninth largest generic company of the world; sales in 125 countries. 9th most trusted brand of the world. Share of 4.8 % in Indian pharmaceutical market. Total revenue of 85507 millions in 2009-10 , 70% of which were generated from exports.
Partnership with Japan’s Daiichi Sankyo in 2008.
Ranbaxy Global Consumer Healthcare in 2002.
Revenue of $ 54 mn with annual growth of 23 % in 2010.
Product
? Revital
? Revital Women
Price
Blister pack of 10 capsules 75 Rs.
Plastic pack of 30 capsules 180 Rs.
Place
1000 distributors in 865 cities. Sold from chemists, general stores and super markets.
11%
Sales Outlets
Chemists General stores Super markets
20%
69%
Segmentation
Men in the age group above 30. All population over the age group of 16
Targeting
Sports persons, professionals and recovering patients.
Men women and diabetes patients.
Positioning
Health supplement for highly active men recovering men. Daily health supplement for everyone above the age of 16
“Jiyo jee bhar ke”
Sales
Largest selling product of Ranbaxy. FY 2010 total revenue of Rs.132 crore. Among top five OTC brands Market Share
Revital
4%
Supractive
9%
Others
87%
Product Life Cycle
180 160 140 120 100 80 60 40
20 0
yr yr yr yr yr yr yr yr yr yr yr 1993 1995 1997 1999 2001 2003 2005 2007 2009 2011 2013
• Low cost of production • Wide distribution channel • Large pool of installed capacities
• Dependence on raw material • Low R & D
S O
• Far saturation point • Health awareness
W
T
• Increasing sales cost • Imitation
References
? en.wikipedia.org/wiki/Revital ? www.myrevital.com/faq.html ? www.ranbaxy.com/investorinformation/annual_pr2010.aspx
? www.ranbaxy.com/investorinformation/finance_archive.aspx
? www.expresspharmaonline.com/.../management02.shtml ? www.slideshare.net/imc-campaign-for-revital-ranbaxy-5914513 - United States
Thank You
doc_614677791.pptx